weight loss with oral semaglutide tirzepatide vs effectiveness โจ ๐๐ก๐ข๐ฌ ๐๐๐๐ค'๐ฌ ๐๐ฎ๐ฌ๐ญ-๐๐๐๐ ๐ข๐ง ๐๐ฎ๐ซ ๐๐๐ฐ๐ฌ๐ฅ๐๐ญ๐ญ๐๐ซ โจ We're breaking down one of the biggest conversations in medical weight loss right now: Tirzepatide vs Semaglutide FDA Approves Oral Semaglutide for
Description
Driven by: Obesity & metabolic syndrome awareness Expanded indications (NASH, PCOS, heart failure, etc.) Employer & insurer push for weight-loss coverage
From pricing to prescriptions, what to know
Prepare for more intensive utilization management as indications expand
A Big Step Toward Affordable Diabetes & Obesity Care in India Alkems introduction of Semaglutide Injection in a pre-filled syringe format marks an important development for Indian healthcare
June 2, 2026 Results of an American College of Radiology-managed retrospective study involving 110,000 womenpresented at the 2026 ASCO Annual Meeting, shows that those who took GLP-1 medications were up to 35% less likely to develop breast cancer than those who did not take GLP-1 drugs. ACR urges funding of a large prospective study to clarify impact of these drugs on cancer incidence and prevention.
